Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Oppenheimer Holdings Inc. - SIC # 6282 - INVESTMENT ADVICE
Ticker
Exchange
SIC #
Website
Latest Ticker
OPY
New York
6282
www.oppenheimer.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Oppenheimer Holdings Inc.
Oppenheimer Picks Apple, Amazon, Alphabet as Top Stock Buys
- Jul 21st, 2026 7:07 am
NextNav (NN) Stock Sees Modest Fair Value Cut As Analysts Weigh Spectrum Upside
- Jul 21st, 2026 3:10 am
ServiceNow gets bearish call before major earnings test
- Jul 20th, 2026 5:37 pm
Jack In The Box (JACK) Stock Sees Fair Value Cut As Analysts Trim Targets
- Jul 19th, 2026 7:07 am
Oppenheimer sends warning on IBM after shares crash
- Jul 17th, 2026 8:07 am
Is Oppenheimer Holdings (OPY) Cheap After Its Run To $119.03?
- Jul 15th, 2026 4:09 pm
Is COMPASS Pathways plc (CMPS) Stock a Psychedelic Medicine Opportunity After Positive COMP360 Data?
- Jul 15th, 2026 3:22 am
Talk About Lousy Timing for a Netflix Analyst Price Target Downgrade
- Jul 13th, 2026 11:07 am
D.R. Horton Quarterly Earnings Poised for Beat Amid Multiple Tailwinds, Oppenheimer Says
- Jul 9th, 2026 11:44 am
Akamai Technology’s (AKAM) Underperformance Can Be Explained By Investors Underestimating Data Center Opportunity
- Jul 6th, 2026 11:50 am
Is Oppenheimer Holdings Inc. (OPY) A Good Stock To Buy Now?
- Jul 3rd, 2026 12:25 pm
Oppenheimer Sees a Long Runway for Comfort Systems (FIX)—Here’s What’s Fueling the Bull Case
- Jul 2nd, 2026 1:54 pm
Why Ascentage Pharma Group Internat (AAPG) Is Gaining Attention in Cancer Drug Development
- Jun 30th, 2026 7:20 am
Is Tyra Biosciences, Inc. (TYRA) Stock a Biotech Opportunity Ahead of Key SURF302 Trial Data?
- Jun 30th, 2026 7:07 am
Is BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock a Rising Oncology Opportunity With KRAS G12C Therapy Potential?
- Jun 30th, 2026 7:06 am
Sezzle Seen as Fast Gross Profit Grower, Oppenheimer Says
- Jun 29th, 2026 9:44 am
Aramark Poised for Solid Third Quarter Amid Revenue Outperformance, Oppenheimer Says
- Jun 29th, 2026 9:11 am
Life Time to Gain From New Centers, Higher-Priced Memberships, Oppenheimer Says
- Jun 25th, 2026 9:11 am
MYR Group (MYRG) Initiated with a Perform Rating at Oppenheimer. Here is Why
- Jun 22nd, 2026 3:29 pm
Oppenheimer Holdings (OPY) Stock Looks Cheap on 11.8x P E But Rich on Cash Flow
- Jun 18th, 2026 7:11 pm
Scroll